Quality Investor
MarketsPortfolioEvidenceTestedCompareWatchlistAbout 

Balchem Corporation

Rank #312Capital ReturnWatchlistCompare with other stocks

BCPC · Nasdaq · Basic Materials

Balchem Corporation (BCPC) — Rank #312 by gross profitability (GP/assets 0.22) · ROE 11.7% · Piotroski F-Score N/A.

As-of 2026-10-30 · CIK 0000009326 · all metrics point-in-time as of the filing date.

About

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.

Show more

It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents.

The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Industry
Specialty Chemicals
Sector
Basic Materials
State
MD
Filer Category
Large accelerated filer
Fiscal Year End
December 31

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

—

P/E (annual)

—

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

1,430

Industry

Specialty Chemicals

Exchange

Nasdaq

11/11

Flags passed

BCPC passes 11/11 quality flags

  • PASS
    Gross margin holding
  • PASS
    Dilution within 2%
  • PASS
    FCF not negative from investment
  • PASS
    Disclosure consistent
  • PASS
    Revenue not declining
  • PASS
    Operating margin holding
  • PASS
    Free cash flow intact
  • PASS
    Passes safety gate
  • PASS
    No competitive retreat
  • PASS
    SBC not compressing margin
  • PASS
    No valuation convergence

Strengths Revenue growth accelerating · Operating leverage expanding · Sequential beat (rev + EPS)

No data Balance sheet — not counted as a pass.

A count of the 12 warning flags that could be evaluated. Unweighted: colour follows the worst flag.

Quality Profile

Profitability

1/1 pass
GP / assets
0.22
Return on equity
11.7%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.28
Current ratio
2.47×
Net cash
$66.26M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
1.7%

Growth

2/2 pass
Revenue growth
8.8%
Piotroski F-Score
N/A
Share dilution
-0.3%

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Does it make money well?

No warning flags · GP/assets 47th percentile of 39 SIC 28 peers

Gross profitability (GP / assets)

0.22

Primary signal (Novy-Marx).

47th pctl of 39 SIC 28 peers

Return on equity

11.7%

Gross margin

35.7%

37th pctl of 39 SIC 28 peers

Revenue growth (YoY)

8.8%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

3.2%

Revenue CAGR (5Y)

8.1%

Earnings CAGR (3Y)

13.7%

FCF CAGR (3Y)

64.1%

Cash Flow Health

Is the cash real?

No warning flags · FCF 12% above net income

Free cash flow

$173.07M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF vs net income

11.8%

(FCF − net income) ÷ |net income|. Positive: cash above earnings. Negative: below.

FCF not below net income

Fails when free cash flow is below net income (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

1.7%

Stock-based comp intensity.

Balance Sheet Strength

Can it survive a storm?

No warning flags · net cash $66.26M

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.28

91st pctl of 35 SIC 28 peers (best = lowest)

Current ratio

2.47×

61st pctl of 39 SIC 28 peers

Quick ratio

1.29×

Net cash

$66.26M

Cash & equivalents minus total debt.

Piotroski F-Score

N/A

Only 8/9 components determinable.

Valuation

Is the price reasonable?

No warning flags

Dividend safety

Composite score

4.2 / 5

Strong
Payout ratio
18.3%5/5 Strong
FCF coverage
6.12×5/5 Strong
Dividend growth streak
10 yr5/5 Strong
Balance-sheet health
D/E 0.28 · IC N/A2/5 Fair

Capital allocation quality

Composite score

3.7 / 5

Good
Share count trend(net buybacks)
-0.3%3/5 Good
Buyback timing
N/AN/A
Dividend growth consistency
10 yr5/5 Strong
Net debt trajectory(deleveraging)
1.5%3/5 Good

Lifecycle Phase History

20202025
Capital Return
Value

Price History

BCPC+23.0% · +4.2% CAGRSPY+82.9% · +12.8% CAGR

View full financial statements →

Source filings on SEC EDGAR: 10-K annual reports · 10-Q quarterly reports